Street picks: 10 stocks ready to pop

Actavis pharmaceuticals
Getty Images
Actavis pharmaceuticals

More than half of the S&P 500 Index components are projected to rise by at least 8 percent in the next 12 months, according to Wall Street analysts, who continue to increase individual share price forecasts even with the stock market hovering around record levels.

CNBC Pro screened for the stocks with the brightest outlooks.